[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_fe906475-5a0f-47c7-8437-61d7c6b92950":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:fe906475-5a0f-47c7-8437-61d7c6b92950,\"}":62},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":29,"indexDatabases":42,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},"fe906475-5a0f-47c7-8437-61d7c6b92950","2023-12-05T05:37:46.007+00:00","2025-11-21T09:51:33.884+00:00",[],"Revista-Colombiana-de-Cardiolog%C3%ADa",{"issn":12,"title":14},{"VOID":13},"01205633",{"EN":15},"Revista Colombiana de Cardiología","PUBLISHER","PENDING",null,0,[21],{"id":22,"createTime":23,"updateTime":24,"relativeEntities":25,"label":26,"description":28,"parentId":18,"standard":18,"scholarHubFieldId":18},"2e748c70-3f53-41a9-99c9-1e3e45a3dc6d","2023-05-29T10:24:06.277+00:00","2023-11-21T08:07:05.812+00:00",[],{"EN":27},"Cardiology and Cardiovascular Medicine",{},[30],{"id":31,"createTime":32,"updateTime":33,"relativeEntities":34,"slug":35,"properties":36,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":40,"url":18,"parentIds":41,"statistic":18},"9cc2f1ab-90c8-48ab-af58-ebefeab2b722","2023-05-29T11:55:49.036+00:00","2025-11-21T09:51:33.877+00:00",[],"Permanyer-Publications-Ltd",{"title":37},{"EN":38},"Permanyer Publications Ltd","AFFILIATION",4,[],[43],{"id":44,"indexDatabase":45,"url":57,"indexYears":58,"academicFieldIds":59,"indexDatabaseRanking":61},"7784e343-8483-46a3-be31-9df5a9d26827",{"id":46,"createTime":47,"updateTime":48,"relativeEntities":49,"label":50,"description":52,"key":54,"publicationTags":55,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":51,"VI":51},"Scopus - Elsevier",{"EN":51,"VI":53},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[56],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F12100154912","2008-2024",[60],"d44e3b1d-4abe-47f2-b4aa-783c24a9f903","NONE",{"meta":63,"data":65},{"total":64},"395",[66,247,345,384,474,575,670,797,892,961],{"id":67,"createTime":68,"updateTime":69,"relativeEntities":70,"slug":71,"properties":72,"entityType":79,"verifyStatus":80,"verifyTime":69,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":82,"fullTextUrl":18,"authors":83,"publicationType":222,"publisherRelationship":223,"citationCount":18,"citationInfo":18,"publishDate":244,"publishYear":245,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"788cd88f-5d9e-4a2f-b09b-05a9de7000e1","2024-01-16T00:15:41.193+00:00","2025-02-18T23:55:03.300+00:00",[],"Characterization-of-dyspnea-in-chronic-diseases-and-heart-failure-in-patients-in-a-Family-Health-Program",{"references":73,"title":75,"doi":77},{"VOID":74},"Hüfner, 2015, Definition, primary examination and differential diagnostics in acute dyspnea, Med Klin Intensivmed Notfmed., 110, 465, 10.1007\u002Fs00063-015-0061-8\nAhmed, 2004, Diagnosis of heart failure in older adults: predictive value of dyspnea at rest, Arch Gerontol Geriatr., 38, 297, 10.1016\u002Fj.archger.2003.12.001\nTessier, 2001, Dyspnea and 8-year mortality among elderly men and women: the PAQUID cohort study, Eur J Epidemiol., 17, 223, 10.1023\u002FA:1017977715073\nPonikowski, 2016, Eur J Heart Fail., 18, 891\nde la Figuera, 2012, ARECO [Suitability and performance of echocardiogram in primary care], Aten Primaria., 44, 190, 10.1016\u002Fj.aprim.2011.03.007\nFarmakis, 2015, Acute heart failure: Epidemiology risk factors prevention. Farmakis D. Parissis J. Lekakis J. Filippatos G, Rev Esp Cardiol., 68, 245, 10.1016\u002Fj.recesp.2014.11.009\nEkundayo, 2009, Value of orthopnea, paroxysmal nocturnal dyspnea, and medications in prospective population studies of incident heart failure, Am J Cardiol., 104, 259, 10.1016\u002Fj.amjcard.2009.03.025\nFonseca, 2004, EPICA Investigators. The diagnosis of heart failure in primary care: value of symptoms and signs, Eur J Heart Fail, 6, 795, 10.1016\u002Fj.ejheart.2004.08.002\nRosa Maria Luiza, 2015, Prevalence of chronic diseases in individuals assisted by the family health program in niteroi, brazil: evaluation of selection bias and protocol, Int J Med Res Health Sci., 4, 587, 10.5958\u002F2319-5886.2015.00113.7\nPhysical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.\nKroenke, 2001, The PHQ-9: validity of a brief depression severity measure, J Gen Intern Med., 16, 606, 10.1046\u002Fj.1525-1497.2001.016009606.x\nSantos, 2013, [Sensitivity and specificity of the Patient Health Questionnaire-9 (PHQ-9) among adults from the general population], Cad Saude Pública., 29, 1533, 10.1590\u002FS0102-311X2013001200006\nBozkurt, 2003, Cardiology patient page Shortness of breath, Circulation., 108, e11, 10.1161\u002F01.CIR.0000075956.36340.78\nBaeza-Trinidad, 2017, Assessment of bendopnea impact on decompensated heart failure, Eur J Heart Fail., 19, 111\nAlbert, 2010, Signs and symptoms of heart failure: are you asking the right questions?, Am J Crit Care., 19, 443, 10.4037\u002Fajcc2009314\nMirza, 2018, COPD Guidelines: A Review of the 2018 GOLD Report, Mayo Clin Proc., 93, 1488, 10.1016\u002Fj.mayocp.2018.05.026\nLainscak, 2015, Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges, ESC Heart Fail., 2, 103, 10.1002\u002Fehf2.12055\nLocke, 2013, Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study, COPD., 10, 588, 10.3109\u002F15412555.2013.781148\nPooler, 2014, Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review, Int J Chron Obstruct Pulmon Dis., 9, 315, 10.2147\u002FCOPD.S53255\nScano, 2013, Dyspnea and emotional states in health and disease, Respir Med., 107, 649, 10.1016\u002Fj.rmed.2012.12.018\nDekker, 2014, Coexisting anxiety and depressive symptoms in patients with heart failure, Eur J Cardiovasc Nurs., 13, 168, 10.1177\u002F1474515113519520\nBattaglia, 2016, Breathe. Asthma in the elderly: a different disease?, 12, 18, 10.1183\u002F20734735.002816\nLee, 2015, New scoring system for the differentiation of chronic obstructive pulmonary disease and asthma, Respirology., 20, 626, 10.1111\u002Fresp.12511\nPerez-David, 1998, Cardiopatía Isquémica: Angina de Pecho cap 6 Estudio de la incapacidad laboral por enfermedades cardiocirculatorias, Instituto Nacional de Medicina y Seguridad del Trabajo, 208\nBrieger, 2004, GRACE Investigators. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events, Chest, 126, 461, 10.1378\u002Fchest.126.2.461\nSiegel, 2017, How radiologic\u002Fclinicopathologic features relate to compressive symptoms in benign thyroid disease, Laryngoscope., 127, 993, 10.1002\u002Flary.26124\nLetamo, 2017, Prevalence and correlates of self-reported chronic non-communicable diseases in Botswana: a cross-sectional study, Int Health., 9, 11, 10.1093\u002Finthealth\u002Fihw052\nPrinja, 2012, Validity of self-reported morbidity, Indian J Med Res., 136, 722\nGure, 2012, Predictors of self-report of heart failure in a population-based survey of older adults, Circ Cardiovasc Qual Outcomes., 5, 396, 10.1161\u002FCIRCOUTCOMES.111.963116\nBarr, 2002, Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses, Am J Epidemiol., 155",{"EN":76},"Characterization of dyspnea in chronic diseases and heart failure in patients in a Family Health Program",{"VOID":78},"10.1016\u002Fj.rccar.2019.07.008","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563319301743",[84,111,127,140,152,165,181,194,207],{"id":85,"sortIndex":19,"researcher":18,"roles":86,"affiliations":88,"properties":108},"90abaca8-234d-4982-b47c-586fddfcd867",[87],"AUTHOR",[89,97],{"id":18,"sortIndex":19,"affiliation":90,"properties":18},{"id":91,"createTime":92,"updateTime":92,"relativeEntities":93,"slug":18,"properties":94,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"b7dc8314-0ff0-436c-96b3-1c0073ad6091","2024-01-16T00:15:41.263+00:00",[],{"title":95},{"VI":96},"Universidade Federal Fluminense, Department of Epidemiology and Biostatistics, Río de Janeiro, Brasil",{"id":98,"sortIndex":99,"affiliation":100,"properties":107},"6c757c41-4c1e-41ed-aa5c-00a4f4c46657",1,{"id":101,"createTime":102,"updateTime":102,"relativeEntities":103,"slug":18,"properties":104,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a9b38899-620b-47b1-82ee-2c52cfc3124a","2024-01-16T00:15:41.222+00:00",[],{"title":105},{"VI":106},"Universidad del Cauca, Departamento de Medicina Social y Salud Familiar, Popayán, Colombia",{},{"title":109},{"VI":110},"Diana M.M. Ceron",{"id":112,"sortIndex":113,"researcher":18,"roles":114,"affiliations":115,"properties":124},"ed71bcd7-1837-4019-8b26-0f601b907cc1",8,[87],[116],{"id":18,"sortIndex":19,"affiliation":117,"properties":18},{"id":118,"createTime":119,"updateTime":119,"relativeEntities":120,"slug":18,"properties":121,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"7ef5adff-b47c-4d41-ab21-3bbab2f0e5b3","2024-01-16T00:15:41.468+00:00",[],{"title":122},{"VI":123},"Universidade Federal Fluminense, Department of Clinical Medicine, Río de Janeiro, Brasil",{"title":125},{"VI":126},"Wolney de Andrade Martins",{"id":128,"sortIndex":129,"researcher":18,"roles":130,"affiliations":131,"properties":137},"ff40d293-d6ec-4003-b60f-135e06b84f73",6,[87],[132],{"id":18,"sortIndex":19,"affiliation":133,"properties":18},{"id":118,"createTime":119,"updateTime":119,"relativeEntities":134,"slug":18,"properties":135,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":136},{"VI":123},{"title":138},{"VI":139},"Julio César Grijalba Velasco",{"id":141,"sortIndex":99,"researcher":18,"roles":142,"affiliations":143,"properties":149},"69efcba9-a814-4fe3-9da6-2a0a452cae70",[87],[144],{"id":18,"sortIndex":19,"affiliation":145,"properties":18},{"id":91,"createTime":92,"updateTime":92,"relativeEntities":146,"slug":18,"properties":147,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":148},{"VI":96},{"title":150},{"VI":151},"Maria Luiza Garcia Rosa",{"id":153,"sortIndex":154,"researcher":18,"roles":155,"affiliations":156,"properties":162},"a293e0b7-5e32-40d2-a7d8-5b8d3bfbe837",7,[87],[157],{"id":18,"sortIndex":19,"affiliation":158,"properties":18},{"id":118,"createTime":119,"updateTime":119,"relativeEntities":159,"slug":18,"properties":160,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":161},{"VI":123},{"title":163},{"VI":164},"Ronaldo Gismondi",{"id":166,"sortIndex":167,"researcher":18,"roles":168,"affiliations":169,"properties":178},"3e610b1c-bbdb-4de6-ba85-3268add23258",3,[87],[170],{"id":18,"sortIndex":19,"affiliation":171,"properties":18},{"id":172,"createTime":173,"updateTime":173,"relativeEntities":174,"slug":18,"properties":175,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"8ffc2d91-6af4-447f-a178-50e96f320a70","2024-01-16T00:15:41.284+00:00",[],{"title":176},{"VI":177},"Universidade Federal Fluminense, Department of Nursing and Administration Fundamentals, Escola de Enfermagem Aurora de Afonso Costa, Departamento de Fundamentos de Enfermagem e Administração, Niteroi, Brazil",{"title":179},{"VI":180},"Dayse M.S. Correia",{"id":182,"sortIndex":183,"researcher":18,"roles":184,"affiliations":185,"properties":191},"70a2087e-28dc-4f60-9b1b-826cd9b82fdf",5,[87],[186],{"id":18,"sortIndex":19,"affiliation":187,"properties":18},{"id":118,"createTime":119,"updateTime":119,"relativeEntities":188,"slug":18,"properties":189,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":190},{"VI":123},{"title":192},{"VI":193},"Evandro T. Mesquita",{"id":195,"sortIndex":196,"researcher":18,"roles":197,"affiliations":198,"properties":204},"ea6d2528-a7d8-43da-9b8b-b7f38cb654ef",2,[87],[199],{"id":18,"sortIndex":19,"affiliation":200,"properties":18},{"id":91,"createTime":92,"updateTime":92,"relativeEntities":201,"slug":18,"properties":202,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":203},{"VI":96},{"title":205},{"VI":206},"Antônio J.L. Jorge",{"id":208,"sortIndex":40,"researcher":18,"roles":209,"affiliations":210,"properties":219},"2bfb4c98-6eb0-4bef-8411-b7e1c5205bec",[87],[211],{"id":18,"sortIndex":19,"affiliation":212,"properties":18},{"id":213,"createTime":214,"updateTime":214,"relativeEntities":215,"slug":18,"properties":216,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"824cff09-3382-40a7-a5b8-c42aebad310f","2024-01-16T00:15:41.379+00:00",[],{"title":217},{"VI":218},"Universidade Federal Fluminense, Department of Pathology, Río de Janeiro, Brasil",{"title":220},{"VI":221},"Hye C. Kang","ARTICLE",{"url":82,"publisher":224,"properties":239},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":225,"slug":10,"properties":226,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":229,"manageAffiliations":230,"indexDatabases":231,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":227,"title":228},{"VOID":13},{"EN":15},[],[],[232],{"id":44,"indexDatabase":233,"url":57,"indexYears":58,"academicFieldIds":238,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":234,"label":235,"description":236,"key":54,"publicationTags":237,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":240,"pages":242},{"VOID":241},"27",{"VOID":243},"13-19","2020-01-01",2020,false,{"id":248,"createTime":249,"updateTime":250,"relativeEntities":251,"slug":252,"properties":253,"entityType":79,"verifyStatus":80,"verifyTime":260,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":261,"fullTextUrl":18,"authors":262,"publicationType":222,"publisherRelationship":322,"citationCount":18,"citationInfo":18,"publishDate":343,"publishYear":344,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"0a1a1d42-b562-4881-a9b5-6402aab83344","2024-01-13T22:04:16.000+00:00","2025-02-07T23:54:00.699+00:00",[],"S%C3%ADndrome-de-reel-una-variante-del-s%C3%ADndrome-de-twiddler",{"references":254,"title":256,"doi":258},{"VOID":255},"Bayliss, 1968, The pacemaker Twiddler's syndrome: A new complication of implantable transvenous pacemakers, Can Med Assoc J, 99, 371\nLarrouse, 2001, Síndrome de Twiddler en un paciente portador de desfibrilador automático implantable: ¿una complicación evitable?, Rev Esp Cardiol, 54, 1456, 10.1016\u002FS0300-8932(01)76531-1\nCarnero-Varo, 1999, Reel syndrome: A new form of Twiddler's syndrome?, Circulation, 100, e45, 10.1161\u002F01.CIR.100.8.e45\nMunawa, 2011, Reel syndrome: A variant form of Twiddler's syndrome, J Arrhythmia, 27, 338\nKonishi, 2012, Twiddler's syndrome detected by patient's complaint of implantable cardioverter-defibrillator rotation in the subcutaneous pocket, J Arrhythmia, 28, 239, 10.1016\u002Fj.joa.2011.12.003\nWollmann, 2011, Reel syndrome. The Ratchet mechanism, Minerva Cardioangiol, 59, 197\nTracy, 2012, Circulation, 126, 1784, 10.1161\u002FCIR.0b013e3182618569\nHiggins, 1998, Recurrent Twiddler's syndrome in a nonthoracotomy ICD system despite a Dacron pouch, Pacing Clin Electrophysiol, 21, 130, 10.1111\u002Fj.1540-8159.1998.tb01072.x",{"ES":257},"Síndrome de reel: una variante del síndrome de twiddler",{"VOID":259},"10.1016\u002Fj.rccar.2015.03.009","2025-02-07T23:54:00.698+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563315000704",[263,278,293,310],{"id":264,"sortIndex":196,"researcher":18,"roles":265,"affiliations":266,"properties":275},"86d78b9a-6b7a-4cfd-8eed-d09f6bcaf20a",[87],[267],{"id":18,"sortIndex":19,"affiliation":268,"properties":18},{"id":269,"createTime":270,"updateTime":270,"relativeEntities":271,"slug":18,"properties":272,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"b8ed4ed2-1a08-4ca2-8139-89eba4377c30","2024-01-30T09:20:05.249+00:00",[],{"title":273},{"VI":274},"Centro internacional de arritmias “Andrea Natale”, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia",{"title":276},{"VI":277},"Juan C. García",{"id":279,"sortIndex":19,"researcher":18,"roles":280,"affiliations":281,"properties":290},"d307351d-fe3d-4065-9e20-e7b588ba2526",[87],[282],{"id":18,"sortIndex":19,"affiliation":283,"properties":18},{"id":284,"createTime":285,"updateTime":285,"relativeEntities":286,"slug":18,"properties":287,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"fb41a349-627b-4677-9af5-3eb9db43c451","2024-01-13T22:04:16.020+00:00",[],{"title":288},{"VI":289},"Servicio de Medicina Interna, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia",{"title":291},{"VI":292},"Diego Echeverri",{"id":294,"sortIndex":99,"researcher":18,"roles":295,"affiliations":296,"properties":307},"c18fa051-a698-4022-951f-f7e89036f1eb",[87],[297],{"id":18,"sortIndex":19,"affiliation":298,"properties":18},{"id":299,"createTime":300,"updateTime":301,"relativeEntities":302,"slug":303,"properties":304,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"0538c7d1-92da-46ea-9bc2-fd334b3aaf1f","2024-01-13T22:04:16.033+00:00","2025-06-11T18:24:58.579+00:00",[],"Servicio-de-Cardiolog%C3%ADa-Cl%C3%ADnica-Adultos-Fundaci%C3%B3n-Cardioinfantil-Instituto-de-Cardiolog%C3%ADa-Bogot%C3%A1-Colombia",{"title":305},{"VI":306},"Servicio de Cardiología Clínica Adultos, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia",{"title":308},{"VI":309},"Ana M. Barón",{"id":311,"sortIndex":167,"researcher":18,"roles":312,"affiliations":313,"properties":319},"8d877dfc-a447-4704-b59f-e3daf39d1011",[87],[314],{"id":18,"sortIndex":19,"affiliation":315,"properties":18},{"id":269,"createTime":270,"updateTime":270,"relativeEntities":316,"slug":18,"properties":317,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":318},{"VI":274},{"title":320},{"VI":321},"Juan D. Ramírez",{"url":261,"publisher":323,"properties":338},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":324,"slug":10,"properties":325,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":328,"manageAffiliations":329,"indexDatabases":330,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":326,"title":327},{"VOID":13},{"EN":15},[],[],[331],{"id":44,"indexDatabase":332,"url":57,"indexYears":58,"academicFieldIds":337,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":333,"label":334,"description":335,"key":54,"publicationTags":336,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":339,"pages":341},{"VOID":340},"22",{"VOID":342},"153-155","2015-05-01",2015,{"id":346,"createTime":347,"updateTime":348,"relativeEntities":349,"slug":350,"properties":351,"entityType":79,"verifyStatus":17,"verifyTime":348,"verifyNote":356,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":357,"fullTextUrl":18,"authors":358,"publicationType":222,"publisherRelationship":359,"citationCount":18,"citationInfo":18,"publishDate":382,"publishYear":383,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"3826b49e-3b90-4dee-9d5e-4125b8e606ab","2024-01-27T22:20:25.071+00:00","2025-01-17T23:53:35.145+00:00",[],"Strain-longitudinal-global-un-par%C3%A1metro-%C3%BAtil-para-evaluar-disfunci%C3%B3n-ventricular-izquierda-subcl%C3%ADnica-en-el-s%C3%ADndrome-metab%C3%B3lico",{"title":352,"doi":354},{"EN":353},"Strain longitudinal global: un parámetro útil para evaluar disfunción ventricular izquierda subclínica en el síndrome metabólico",{"VOID":355},"10.1016\u002Fj.rccar.2015.10.008","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563315002272",[],{"url":357,"publisher":360,"properties":375},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":361,"slug":10,"properties":362,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":365,"manageAffiliations":366,"indexDatabases":367,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":363,"title":364},{"VOID":13},{"EN":15},[],[],[368],{"id":44,"indexDatabase":369,"url":57,"indexYears":58,"academicFieldIds":374,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":370,"label":371,"description":372,"key":54,"publicationTags":373,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":376,"pages":378,"issue":380},{"VOID":377},"23",{"VOID":379},"112-119",{"VOID":381},"2","2016-03-01",2016,{"id":385,"createTime":386,"updateTime":387,"relativeEntities":388,"slug":389,"properties":390,"entityType":79,"verifyStatus":80,"verifyTime":387,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":397,"fullTextUrl":18,"authors":398,"publicationType":222,"publisherRelationship":453,"citationCount":18,"citationInfo":18,"publishDate":473,"publishYear":383,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"b9f89bf1-a1ee-4c31-88c5-75fef69dd22e","2023-12-13T22:10:14.651+00:00","2024-12-14T23:53:26.539+00:00",[],"Patrones-de-prescripci%C3%B3n-de-los-nuevos-anticoagulantes-orales-y-sus-costos-econ%C3%B3micos-en-Colombia",{"references":391,"title":393,"doi":395},{"VOID":392},"Ageno, 2012, Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e44S, 10.1378\u002Fchest.11-2292\nWigle, 2013, Updated guidelines on outpatient anticoagulation, Am Fam Physician., 87, 556\nGutierrez, 2011, Atrial fibrillation: diagnosis and treatment, Am Fam Physician., 83, 61\nXu, 2012, Novel anticoagulants for non-valvular atrial fibrillation, Heart Lung Circ., 21, 463, 10.1016\u002Fj.hlc.2012.04.002\nPotpara, 2013, Novel oral anticoagulants in non-valvular atrial fibrillation, Best Pract Res Clin Haematol., 26, 115, 10.1016\u002Fj.beha.2013.07.008\nKansal, 2013, Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation, Best Pract Res Clin Haematol., 26, 225, 10.1016\u002Fj.beha.2013.07.012\nRiva, 2013, Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients, Thromb Res., 131, S67, 10.1016\u002FS0049-3848(13)70026-4\nLittle, 2012, New oral anticoagulants: will they replace warfarin?, Oral Surg Oral Med Oral Pathol Oral Radiol, 113, 575, 10.1016\u002Fj.oooo.2011.10.006\nCapodanno, 2013, Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients, Int J Cardiol., 167, 1237, 10.1016\u002Fj.ijcard.2012.03.148\nO’Dell, 2012, New oral anticoagulants for atrial fibrillation: a review of clinical trials, Clin Ther, 34, 894, 10.1016\u002Fj.clinthera.2012.01.019\nMcManus, 2012, Thromboembolism, Am Fam Physician, 85, 188\nGómez-Outes, 2012, Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons, BMJ, 344, e3675, 10.1136\u002Fbmj.e3675\nFalck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e278S, 10.1378\u002Fchest.11-2404\nPatel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med., 365, 883, 10.1056\u002FNEJMoa1009638\nConnolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med., 361, 1139, 10.1056\u002FNEJMoa0905561\nGranger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med., 365, 981, 10.1056\u002FNEJMoa1107039\nConnolly, 2011, Apixaban in patients with atrial fibrillation, N Engl J Med., 364, 806, 10.1056\u002FNEJMoa1007432\nMarcus, 2010, European ancestry as a risk factor for atrial fibrillation in African Americans, Circulation., 122, 2009, 10.1161\u002FCIRCULATIONAHA.110.958306\nJanuary, 2014, 2014 AHA\u002FACC\u002FHRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\u002FAmerican Heart Association Task Force on practice guidelines and the Heart Rhythm Society, Circulation., 130, 2071, 10.1161\u002FCIR.0000000000000040\nRao, 2014, Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute, Scientifica (Cairo)., 2014, 901586\nKonstantinides, 2014, 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J., 35, 3033, 10.1093\u002Feurheartj\u002Fehu283\nAlbert, 2014, Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications, Heart Lung., 43, 48, 10.1016\u002Fj.hrtlng.2013.10.014\nGómez-Outes, 2013, Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups, Thrombosis., 2013, 640723, 10.1155\u002F2013\u002F640723\nLevy, 2014, New oral anticoagulant-induced bleeding: clinical presentation and management, Clin Lab Med., 34, 575, 10.1016\u002Fj.cll.2014.06.004\nHolster, 2013, New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis, Gastroenterology., 145, 10.1053\u002Fj.gastro.2013.02.041\nAgnelli, 2013, New oral anticoagulants for the treatment of venous thromboembolism, Best Pract Res Clin Haematol., 151, 10.1016\u002Fj.beha.2013.07.005\nKang, 2014, Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism, Thromb Res., 133, 1145, 10.1016\u002Fj.thromres.2014.03.035\nKerr M. Cost and benefits of Antithrombotic therapy in atrial fibrilation in England: an economic analysis based on GRASP-AF. National Health System (NHS). 2014. fecha de consulta: abril 24 del 2015. Disponible en: http:\u002F\u002Fwww.nhsiq.nhs.uk\u002Fmedia\u002F2566750\u002Faf_economic_analysis_final.pdf\nStefanini, 2013, Drug-eluting coronary-artery stents, N Engl J Med., 368, 254, 10.1056\u002FNEJMra1210816\nHuang, 2013, The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: a systematic review, PLoS One., 8, e65754, 10.1371\u002Fjournal.pone.0065754\nHong, 2014, Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons, J Clin Neurol., 10, 189, 10.3988\u002Fjcn.2014.10.3.189\nDewilde, 2014, Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review, J Am Coll Cardiol., 64, 1270, 10.1016\u002Fj.jacc.2014.06.1193\nDzeshka, 2014, Anticoagulant Therapy for Atrial Fibrillation, Cardiol Clin., 32, 585, 10.1016\u002Fj.ccl.2014.07.009\nGuérin, 2013, Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy, Int J Cardiol., 167, 564, 10.1016\u002Fj.ijcard.2012.01.047\nGorczyca-Michta, 2013, Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension, Kardiol Pol., 71, 352, 10.5603\u002FKP.2013.0062\nVyssoulis, 2013, Metabolic syndrome and atrial fibrillation in patients with essential hypertension, Nutr Metab Cardiovasc Dis., 23, 109, 10.1016\u002Fj.numecd.2011.03.011\nJiří Widimský, 2012, Arterial hypertension and atrial fibrillation: Selecting antihypertensive therapy, Cor et Vasa., 54, e248, 10.1016\u002Fj.crvasa.2012.08.004\nLane, 2012, Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation, Circulation., 126, 860, 10.1161\u002FCIRCULATIONAHA.111.060061\nKoju, 2014, Association of cardiovascular risk factors and coronary artery lesion among coronary artery disease patients, Kathmandu Univ Med J (KUMJ)., 12, 137\nAristizábal, 2012, Consideraciones prácticas para el uso de los nuevos anticoagulantes orales, Rev Colomb Cardiol., 19, 135\nMachado-Alba, 2008, Prescription patterns for antilipidemic drugs in a group of Colombian patients, Rev Panam Salud Publica., 23, 179",{"ES":394},"Patrones de prescripción de los nuevos anticoagulantes orales y sus costos económicos en Colombia",{"VOID":396},"10.1016\u002Fj.rccar.2015.08.005","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563315001941",[399,414,426,441],{"id":400,"sortIndex":19,"researcher":18,"roles":401,"affiliations":402,"properties":411},"380c4d9a-9872-4665-9565-fb668c335dbc",[87],[403],{"id":18,"sortIndex":19,"affiliation":404,"properties":18},{"id":405,"createTime":406,"updateTime":406,"relativeEntities":407,"slug":18,"properties":408,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"2c792cb8-b24f-4aa5-a6b0-bed562286f2f","2023-12-13T22:10:14.662+00:00",[],{"title":409},{"VI":410},"Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira–Audifarma, S.A., Pereira, Colombia",{"title":412},{"VI":413},"Jorge E. Machado-Alba",{"id":415,"sortIndex":99,"researcher":18,"roles":416,"affiliations":417,"properties":423},"675c9418-257f-4ab1-aa8e-339bb02d933f",[87],[418],{"id":18,"sortIndex":19,"affiliation":419,"properties":18},{"id":405,"createTime":406,"updateTime":406,"relativeEntities":420,"slug":18,"properties":421,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":422},{"VI":410},{"title":424},{"VI":425},"Santiago García-Betancur",{"id":427,"sortIndex":196,"researcher":18,"roles":428,"affiliations":429,"properties":438},"a575553f-20cb-4889-8eab-7fd2c1edbc5f",[87],[430],{"id":18,"sortIndex":19,"affiliation":431,"properties":18},{"id":432,"createTime":433,"updateTime":433,"relativeEntities":434,"slug":18,"properties":435,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"80a54a55-e62f-40b8-aa4a-cba2fc1f8ca4","2023-12-13T22:10:14.690+00:00",[],{"title":436},{"VI":437},"Asociación Colombiana Médica Estudiantil (ACOME)",{"title":439},{"VI":440},"Federico Villegas-Cardona",{"id":442,"sortIndex":167,"researcher":18,"roles":443,"affiliations":444,"properties":450},"55c5154b-ee7d-4441-bf0d-7bb0a42954fb",[87],[445],{"id":18,"sortIndex":19,"affiliation":446,"properties":18},{"id":405,"createTime":406,"updateTime":406,"relativeEntities":447,"slug":18,"properties":448,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":449},{"VI":410},{"title":451},{"VI":452},"Diego Alejandro Medina-Morales",{"url":397,"publisher":454,"properties":469},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":455,"slug":10,"properties":456,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":459,"manageAffiliations":460,"indexDatabases":461,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":457,"title":458},{"VOID":13},{"EN":15},[],[],[462],{"id":44,"indexDatabase":463,"url":57,"indexYears":58,"academicFieldIds":468,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":464,"label":465,"description":466,"key":54,"publicationTags":467,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":470,"pages":471},{"VOID":377},{"VOID":472},"277-285","2016-07-01",{"id":475,"createTime":476,"updateTime":477,"relativeEntities":478,"slug":479,"properties":480,"entityType":79,"verifyStatus":80,"verifyTime":477,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":487,"fullTextUrl":18,"authors":488,"publicationType":222,"publisherRelationship":552,"citationCount":18,"citationInfo":18,"publishDate":573,"publishYear":574,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"babe2edc-c381-411d-acc5-32b81cfd0b16","2024-01-02T05:41:34.987+00:00","2025-02-12T23:45:44.872+00:00",[],"Prevalencia-de-infarto-criptog%C3%A9nico-en-pacientes-con-diagn%C3%B3stico-de-infarto-cerebral",{"references":481,"title":483,"doi":485},{"VOID":482},"Sacco, 2013, An updated definition of stroke for the 21st. century: a statement for healthcare professionals from the American Heart Association\u002FAmerican Stroke Association, Stroke., 44, 2064, 10.1161\u002FSTR.0b013e318296aeca\nAdams, 1993, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke., 24, 35, 10.1161\u002F01.STR.24.1.35\nKolominsky-Rabas, 2001, Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study, Stroke., 32, 2735, 10.1161\u002Fhs1201.100209\nTai, 2014, Secondary prevention of atherothrombotic or cryptogenic stroke, Circulation., 129, 527, 10.1161\u002FCIRCULATIONAHA.112.000658\nSacco, 1989, Infarcts of undetermined cause: the NINCDS Stroke Data Bank, Ann Neurol., 25, 382, 10.1002\u002Fana.410250410\nPeña, 2001, Acta Neurol Colomb, 17, 5\nBayona Ortiz, 2014, Utilidad del código de ACV en pacientes con accidente cerebrovascular agudo: comparación de dos períodos de tiempo, Acta Neurol Colomb., 30, 7\nBayona Ortiz, 2015, Concordancia en la realización del triaje entre enfermería y neurología en pacientes con accidente cerebrovascular isquémico en un hospital universitario: un estudio de corte transversal en un hospital de Bogotá, Rev Colomb Enferm., 10, 7\nMarini, 2005, Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study, Stroke., 36, 1115, 10.1161\u002F01.STR.0000166053.83476.4a\nHart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology. 13(4):429-38.\nNtaios, 2015, Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis, Stroke., 46, 176, 10.1161\u002FSTROKEAHA.114.007240\nSanna, 2014, Cryptogenic stroke and underlying atrial fibrillation, N Engl J Med., 370, 2478, 10.1056\u002FNEJMoa1313600\nGladstone, 2014, Atrial fibrillation in patients with cryptogenic stroke, N Engl J Med., 370, 2467, 10.1056\u002FNEJMoa1311376\nHealey, 2012, Subclinical atrial fibrillation and the risk of stroke, N Eng J Med., 366, 120, 10.1056\u002FNEJMoa1105575\nMacle, 2015, The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines, Can J Cardiol., 31, 1207, 10.1016\u002Fj.cjca.2015.06.005\nVallejos, 2012, Prognosis of cryptogenic ischemic stroke: a prospective single-center study in Chile, J Stroke Cardiovasc Dis., 21, 621, 10.1016\u002Fj.jstrokecerebrovasdis.2011.02.005\nArauz, 2012, Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale, Int J Stroke., 7, 631, 10.1111\u002Fj.1747-4949.2011.00641.x\nLamy, 2002, Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA Study, Stroke., 33, 706, 10.1161\u002Fhs0302.104543\nLiberman, 2013, Cryptogenic stroke: how to define it? How to treat it?, Curr Cardiol Rep., 15, 423, 10.1007\u002Fs11886-013-0423-x\nSaver, 2016, Cryptogenic stroke, N Eng J Med., 374, 2065, 10.1056\u002FNEJMcp1503946\nKishore, 2014, Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis, Stroke., 45, 520, 10.1161\u002FSTROKEAHA.113.003433\nCarroll, 2013, Closure of patent foramen ovale versus medical therapy after cryptogenic stroke, N Engl J Med., 368, 1092, 10.1056\u002FNEJMoa1301440\nFurlan, 2012, Closure or medical therapy for cryptogenic stroke with patent foramen ovale, N Engl J Med., 366, 991, 10.1056\u002FNEJMoa1009639\nMeier, 2013, Percutaneous closure of patent foramen ovale in cryptogenic embolism, N Engl J Med., 368, 1083, 10.1056\u002FNEJMoa1211716",{"ES":484},"Prevalencia de infarto criptogénico en pacientes con diagnóstico de infarto cerebral",{"VOID":486},"10.1016\u002Fj.rccar.2016.06.010","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563316301012",[489,504,516,528,540],{"id":490,"sortIndex":196,"researcher":18,"roles":491,"affiliations":492,"properties":501},"a0dc4bba-45e1-42a3-93ba-98c51c2c4212",[87],[493],{"id":18,"sortIndex":19,"affiliation":494,"properties":18},{"id":495,"createTime":496,"updateTime":496,"relativeEntities":497,"slug":18,"properties":498,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9f0f962d-8fb5-472e-9d90-c8e30a5c0f4b","2024-01-02T05:41:34.999+00:00",[],{"title":499},{"VI":500},"Hospital Universitario Fundación Santa Fe de Bogotá, Departamento de Neurología, Universidad de los Andes, Bogotá, Colombia",{"title":502},{"VI":503},"María C. Valencia-Mendoza",{"id":505,"sortIndex":167,"researcher":18,"roles":506,"affiliations":507,"properties":513},"1ec71f72-6b80-4f49-a409-72bd6e2553ea",[87],[508],{"id":18,"sortIndex":19,"affiliation":509,"properties":18},{"id":495,"createTime":496,"updateTime":496,"relativeEntities":510,"slug":18,"properties":511,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":512},{"VI":500},{"title":514},{"VI":515},"Mariajose Centeno-Padilla",{"id":517,"sortIndex":19,"researcher":18,"roles":518,"affiliations":519,"properties":525},"fe2471a3-1e4e-4ddf-8ccc-3ac58bec94d9",[87],[520],{"id":18,"sortIndex":19,"affiliation":521,"properties":18},{"id":495,"createTime":496,"updateTime":496,"relativeEntities":522,"slug":18,"properties":523,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":524},{"VI":500},{"title":526},{"VI":527},"Hernán F. Bayona-Ortiz",{"id":529,"sortIndex":99,"researcher":18,"roles":530,"affiliations":531,"properties":537},"9b3980d6-6eb1-460a-801c-b902417d9cd7",[87],[532],{"id":18,"sortIndex":19,"affiliation":533,"properties":18},{"id":495,"createTime":496,"updateTime":496,"relativeEntities":534,"slug":18,"properties":535,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":536},{"VI":500},{"title":538},{"VI":539},"Carlos F. Martínez-Rubio",{"id":541,"sortIndex":40,"researcher":18,"roles":542,"affiliations":543,"properties":549},"ed97ce5b-c11b-4cf4-985d-61888ad83e64",[87],[544],{"id":18,"sortIndex":19,"affiliation":545,"properties":18},{"id":495,"createTime":496,"updateTime":496,"relativeEntities":546,"slug":18,"properties":547,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":548},{"VI":500},{"title":550},{"VI":551},"Santiago A. Ortiz-Galindo",{"url":487,"publisher":553,"properties":568},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":554,"slug":10,"properties":555,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":558,"manageAffiliations":559,"indexDatabases":560,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":556,"title":557},{"VOID":13},{"EN":15},[],[],[561],{"id":44,"indexDatabase":562,"url":57,"indexYears":58,"academicFieldIds":567,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":563,"label":564,"description":565,"key":54,"publicationTags":566,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":569,"pages":571},{"VOID":570},"24",{"VOID":572},"211-216","2017-05-01",2017,{"id":576,"createTime":577,"updateTime":578,"relativeEntities":579,"slug":580,"properties":581,"entityType":79,"verifyStatus":80,"verifyTime":578,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":588,"fullTextUrl":18,"authors":589,"publicationType":222,"publisherRelationship":650,"citationCount":18,"citationInfo":18,"publishDate":382,"publishYear":383,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"cb0b1974-2846-44d3-93bf-daa6824183cb","2024-01-08T10:20:56.201+00:00","2025-01-01T23:44:54.072+00:00",[],"Cardiotoxicidad-inducida-por-la-quimioterapia-desde-las-bases-moleculares-hasta-la-perspectiva-cl%C3%ADnica",{"references":582,"title":584,"doi":586},{"VOID":583},"Siegel, 2015, Cancer statistics, 2015: Cancer Statistics, 2015, CA Cancer J Clin., 65, 5, 10.3322\u002Fcaac.21254\nDeSantis, 2014, Cancer treatment and survivorship statistics, 2014: Cancer Treatment and Survivorship Statistics, 2014, CA Cancer J Clin., 64, 252, 10.3322\u002Fcaac.21235\nYusuf, 2011, Radiation-induced heart disease: a clinical update, Cardiol Res Pract., 2011, 317659, 10.4061\u002F2011\u002F317659\nCarver, 2007, American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects, J Clin Oncol Off J Am Soc Clin Oncol., 25, 3991, 10.1200\u002FJCO.2007.10.9777\nFlorescu, 2013, Chemotherapy-induced Cardiotoxicity, Mædica, 8, 59\nSeidman, 2002, Cardiac dysfunction in the trastuzumab clinical trials experience, J Clin Oncol Off J Am Soc Clin Oncol., 20, 1215, 10.1200\u002FJCO.20.5.1215\nJiji, 2012, Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs, J Nucl Cardiol Off Publ Am Soc Nucl Cardiol., 19, 377, 10.1007\u002Fs12350-012-9512-2\nAlbini, 2010, Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention, J Natl Cancer Inst., 102, 14, 10.1093\u002Fjnci\u002Fdjp440\nDolci, 2008, Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use, Am J Clin Pathol., 130, 688, 10.1309\u002FAJCPB66LRIIVMQDR\nFrishman, 1997, Cardiovascular toxicity with cancer chemotherapy, Curr Probl Cancer., 21, 301, 10.1016\u002FS0147-0272(97)80001-3\nPai, 2000, Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention, Drug Saf., 22, 263, 10.2165\u002F00002018-200022040-00002\nRang HP. Rang et Dale's pharmacology. Edinburgh [u.a.]: Elsevier, Churchill Livingstone; 2016.\nFigueredo, 2011, The Negative Effects of Medications and Nonprescribed Drugs on the Heart, Am J Med., 124, 480, 10.1016\u002Fj.amjmed.2010.11.031\nZylberman, 2013, Consenso de diagnóstico, prevención y tratamiento de la cardiotoxicidad por tratamiento médico del cáncer, Rev Argent Cardiol., 81, 1\nBrana, 2010, Cardiotoxicity, Ann Oncol., 21, vii173, 10.1093\u002Fannonc\u002Fmdq295\nLefrak, 1973, A clinicopathologic analysis of adriamycin cardiotoxicity, Cancer., 32, 302, 10.1002\u002F1097-0142(197308)32:2\u003C302::AID-CNCR2820320205>3.0.CO;2-2\nEwer, 1984, A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin, J Clin Oncol Off J Am Soc Clin Oncol., 2, 112, 10.1200\u002FJCO.1984.2.2.112\n2013, 1454\nKhakoo, 2011, Cardiotoxicity due to cancer therapy, Tex Heart Inst J Tex Heart Inst St Lukes Episcop Hosp Tex Child Hosp., 38, 253\nSchlitt, 2014, Cardiotoxicity and oncological treatments, Dtsch Ärztebl Int., 111, 161\nHurtado, 2011, Cardiotoxicidad por quimioterapia Un enfoque práctico para el clínico, Insufic Card., 6, 131\nAdão, 2013, Cardiotoxicidade associada à terapêutica oncológica: mecanismos fisiopatológicos e estratégias de prevenção, Rev Port Cardiol., 32, 395, 10.1016\u002Fj.repc.2012.11.002\nSlørdal, 2006, Heart failure induced by non-cardiac drugs, Drug Saf., 29, 567, 10.2165\u002F00002018-200629070-00003\nCurigliano, 2012, Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines, Ann Oncol., 23, vii155, 10.1093\u002Fannonc\u002Fmds293\nOzcelik, 2002, Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy, Proc Natl Acad Sci., 99, 8880, 10.1073\u002Fpnas.122249299\nSerrano, 2012, Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors, Ann Oncol Off J Eur Soc Med Oncol ESMO., 23, 897, 10.1093\u002Fannonc\u002Fmdr348\nDi Cosimo, 2011, Heart to heart with trastuzumab: a review on cardiac toxicity, Target Oncol., 6, 189, 10.1007\u002Fs11523-011-0203-8\nChavez-MacGregor, 2013, Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer, J Clin Oncol., 31, 4222, 10.1200\u002FJCO.2013.48.7884\nOrphanos, 2009, Cardiotoxicity induced by tyrosine kinase inhibitors, Acta Oncol., 48, 964, 10.1080\u002F02841860903229124\nLiu, 2015, Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate, Cell Death Dis., 6, e1822, 10.1038\u002Fcddis.2015.183\nBovelli, 2010, Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines, Ann Oncol., 21, v277, 10.1093\u002Fannonc\u002Fmdq200\nPlana, 2014, Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr., 27, 911, 10.1016\u002Fj.echo.2014.07.012\nDogru, 2013, Evaluation of Cardiotoxicity via Speckle-Tracking Echocardiography in Patients Treated with Anthracyclines, Oncol Res Treat., 36, 10.1159\u002F000356850\nReagan, 2013, Comparison of Cardiac Troponin I and T, Including the Evaluation of an Ultrasensitive Assay, as Indicators of Doxorubicin-induced Cardiotoxicity, Toxicol Pathol., 41, 1146, 10.1177\u002F0192623313482056\nLotrionte, 2013, Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity, Am J Cardiol., 112, 1980, 10.1016\u002Fj.amjcard.2013.08.026\nSmith, 2010, Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials, BMC Cancer., 10, 337, 10.1186\u002F1471-2407-10-337\nRahman, 2007, Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation, Int J Nanomedicine., 2, 567\nBosch, 2013, Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies, J Am Coll Cardiol., 61, 2355, 10.1016\u002Fj.jacc.2013.02.072\nSmiseth, 2013, Cardioprotection During Chemotherapy, J Am Coll Cardiol., 61, 2363, 10.1016\u002Fj.jacc.2013.02.073",{"ES":585},"Cardiotoxicidad inducida por la quimioterapia desde las bases moleculares hasta la perspectiva clínica",{"VOID":587},"10.1016\u002Fj.rccar.2015.10.002","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS012056331500220X",[590,605,620,635],{"id":591,"sortIndex":167,"researcher":18,"roles":592,"affiliations":593,"properties":602},"3704671d-d5ae-4303-b87b-1e4267f79a29",[87],[594],{"id":18,"sortIndex":19,"affiliation":595,"properties":18},{"id":596,"createTime":597,"updateTime":597,"relativeEntities":598,"slug":18,"properties":599,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c8a7a718-f383-4cc0-8cc4-c8b72d6fb5c9","2024-01-08T10:20:56.251+00:00",[],{"title":600},{"VI":601},"Clínica Las Américas - CEMDE–Fundación Ciencia Vital- Cardiovital Investigaciones. Medellín, Colombia",{"title":603},{"VI":604},"Nicolás Jaramillo",{"id":606,"sortIndex":196,"researcher":18,"roles":607,"affiliations":608,"properties":617},"eb946895-7e9d-471f-b60a-79bf3f08d1d2",[87],[609],{"id":18,"sortIndex":19,"affiliation":610,"properties":18},{"id":611,"createTime":612,"updateTime":612,"relativeEntities":613,"slug":18,"properties":614,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"3a489eed-08f5-4363-ac04-eb3cb5c3abbe","2024-01-08T10:20:56.237+00:00",[],{"title":615},{"VI":616},"Hospital General de Medellín\u002FClínica SOMA–CEMDE. Universidad CES. Medellín, Colombia",{"title":618},{"VI":619},"Marie C. Berrouet",{"id":621,"sortIndex":19,"researcher":18,"roles":622,"affiliations":623,"properties":632},"9d8a8244-88e4-4766-90b6-bb1e0fc603ad",[87],[624],{"id":18,"sortIndex":19,"affiliation":625,"properties":18},{"id":626,"createTime":627,"updateTime":627,"relativeEntities":628,"slug":18,"properties":629,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"7bde831b-af12-4fc6-b8ce-405a94527711","2024-01-08T10:20:56.211+00:00",[],{"title":630},{"VI":631},"Universidad CES. Cardiovital Investigaciones - CEMDE–Universidad CES. Medellín, Colombia",{"title":633},{"VI":634},"Camilo A. Velásquez",{"id":636,"sortIndex":99,"researcher":18,"roles":637,"affiliations":638,"properties":647},"8e9b17a6-f4ad-44c0-b8b7-511e82bda5d7",[87],[639],{"id":18,"sortIndex":19,"affiliation":640,"properties":18},{"id":641,"createTime":642,"updateTime":642,"relativeEntities":643,"slug":18,"properties":644,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"cb48a09d-9a87-4d02-9bde-083a06d70e73","2024-01-08T10:20:56.223+00:00",[],{"title":645},{"VI":646},"Departamento de Medicina Interna, Rutgers University - New Jersey Medical School. Newark, New Jersey, Estados Unidos",{"title":648},{"VI":649},"Miguel González",{"url":588,"publisher":651,"properties":666},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":652,"slug":10,"properties":653,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":656,"manageAffiliations":657,"indexDatabases":658,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":654,"title":655},{"VOID":13},{"EN":15},[],[],[659],{"id":44,"indexDatabase":660,"url":57,"indexYears":58,"academicFieldIds":665,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":661,"label":662,"description":663,"key":54,"publicationTags":664,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":667,"pages":668},{"VOID":377},{"VOID":669},"104-111",{"id":671,"createTime":672,"updateTime":673,"relativeEntities":674,"slug":675,"properties":676,"entityType":79,"verifyStatus":80,"verifyTime":673,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":683,"fullTextUrl":18,"authors":684,"publicationType":222,"publisherRelationship":776,"citationCount":18,"citationInfo":18,"publishDate":796,"publishYear":383,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"6f993f3f-8cee-418d-9cc7-93f3dc5292a7","2023-12-23T10:08:52.483+00:00","2025-01-16T23:41:40.349+00:00",[],"Puntos-de-corte-de-per%C3%ADmetro-de-cintura-para-el-diagn%C3%B3stico-de-obesidad-abdominal-en-poblaci%C3%B3n-colombiana-usando-bioimpedanciometr%C3%ADa-como-est%C3%A1ndar-de-referencia",{"references":677,"title":679,"doi":681},{"VOID":678},"Kanhai, 2012, The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease, Int J Obes., 36, 695, 10.1038\u002Fijo.2011.115\nPladevall, 2006, A single factor underlies the metabolic syndrome: a confirmatory factor analysis, Diabetes Care., 29, 113, 10.2337\u002Fdiacare.29.01.06.dc05-0862\nAlberti, 2009, Circulation., 120, 1640, 10.1161\u002FCIRCULATIONAHA.109.192644\nAschner, 2011, Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women, Diabetes Res Clin Pract., 93, 243, 10.1016\u002Fj.diabres.2011.05.002\nXu, 2011, Comparisons of body-composition prediction accuracy: a study of 2 bioelectric impedance consumer devices in healthy Chinese persons using DXA and MRI as criteria methods, J Clin Densitom., 14, 458, 10.1016\u002Fj.jocd.2011.04.001\nValenzuela-Landaeta, 2012, Nutritional assessment for cancer patient, Nutr Hosp., 27, 516\nOzhan, 2012, Performance of bioelectrical impedance analysis in the diagnosis of metabolic syndrome, J Investig Med., 60, 587, 10.2310\u002FJIM.0b013e318244e2d9\nNagai, 2010, Estimating visceral fat area by multifrequency bioelectrical impedance, Diabetes care., 33, 1077, 10.2337\u002Fdc09-1099\nAlberti, 2005, The metabolic syndrome--a new worldwide definition, Lancet., 366, 1059, 10.1016\u002FS0140-6736(05)67402-8\nChackrewarthy, 2013, A comparison between revised NCEP ATP III and IDF definitions in diagnosing metabolic syndrome in an urban Sri Lankan population: The Ragama Health Study, ISRN Endocrinology., 2013, 320176, 10.1155\u002F2013\u002F320176\nSung KC, Rhee EJ, Ryu S, Kim BJ, Kim BS, Lee WY, et al. Increased cardiovascular mortality in subjects with metabolic syndrome is largely attributable to diabetes and hypertension in 159 971 korean adults. J Clin Endocrinol Metab. 2015:jc20144031. [Epub ahead of print].\nZimmet, 2005, A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results, Rev Esp Cardiol., 58, 1371, 10.1016\u002FS0300-8932(05)74065-3\nUnno, 2012, The utility of visceral fat level by bioelectrical impedance analysis in the screening of metabolic syndrome - the results of the Kyushu and Okinawa Population Study (KOPS), J Atheroscler Thromb., 19, 462, 10.5551\u002Fjat.11528\nStanley, 2015, Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies, Growth Horm IGF Res., 25, 59, 10.1016\u002Fj.ghir.2014.12.005\nAndersson, 2011, Visceral fat cell lipolysis and cardiovascular risk factors in obesity, Horm Metab Res, 43, 809, 10.1055\u002Fs-0031-1287767\nDespres, 2007, Cardiovascular disease under the influence of excess visceral fat, Crit Path Cardiol., 6, 51, 10.1097\u002FHPC.0b013e318057d4c9\nRuiz, 2012, (International Day for the Evaluation of Abdominal Obesity): Primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia, Biomedica., 32, 610, 10.7705\u002Fbiomedica.v32i4.799\nKo, 2007, Waist circumference and BMI cut-off based on 10-year cardiovascular risk: evidence for central pre-obesity, Obesity., 15, 2832, 10.1038\u002Foby.2007.336\nAschner, 2009, Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America, J Clin Hypertens., 11, 769, 10.1111\u002Fj.1559-4572.2008.00051.x\nNaboush, 2013, Measuring visceral and hepatic fat in clinical practice and clinical research, Endocr Pract., 19, 587, 10.4158\u002FEP12331.OR",{"ES":680},"Puntos de corte de perímetro de cintura para el diagnóstico de obesidad abdominal en población colombiana usando bioimpedanciometría como estándar de referencia",{"VOID":682},"10.1016\u002Fj.rccar.2015.07.011","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563315001862",[685,700,715,732,747,759],{"id":686,"sortIndex":167,"researcher":18,"roles":687,"affiliations":688,"properties":697},"0c425168-71a2-4895-aa7f-19856fc0da2c",[87],[689],{"id":18,"sortIndex":19,"affiliation":690,"properties":18},{"id":691,"createTime":692,"updateTime":692,"relativeEntities":693,"slug":18,"properties":694,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"ffcc3958-533a-4485-af01-168196f469d7","2023-12-23T10:08:52.708+00:00",[],{"title":695},{"VI":696},"Universidad El Rosario, Bogotá, Colombia",{"title":698},{"VI":699},"Adelaida Reino",{"id":701,"sortIndex":40,"researcher":18,"roles":702,"affiliations":703,"properties":712},"e4b3848f-e389-43ef-8600-359eaa13eaf1",[87],[704],{"id":18,"sortIndex":19,"affiliation":705,"properties":18},{"id":706,"createTime":707,"updateTime":707,"relativeEntities":708,"slug":18,"properties":709,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c96096ea-fd34-4ea1-88bd-ae6a67dfa84d","2024-02-10T19:50:16.727+00:00",[],{"title":710},{"VI":711},"Universidad El Bosque, Bogotá, Colombia",{"title":713},{"VI":714},"July Ramírez",{"id":716,"sortIndex":196,"researcher":18,"roles":717,"affiliations":718,"properties":729},"ee56d6dd-3e51-402e-80d7-9875653710eb",[87],[719],{"id":18,"sortIndex":19,"affiliation":720,"properties":18},{"id":721,"createTime":722,"updateTime":723,"relativeEntities":724,"slug":725,"properties":726,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"30f74935-5706-43ae-96fb-6c612c1f206b","2023-12-12T13:58:46.047+00:00","2024-09-26T20:42:01.241+00:00",[],"Universidad-Nacional-de-Colombia-Bogot%C3%A1-Colombia",{"title":727},{"VI":728},"Universidad Nacional de Colombia, Bogotá, Colombia",{"title":730},{"VI":731},"Ángela Díaz",{"id":733,"sortIndex":19,"researcher":18,"roles":734,"affiliations":735,"properties":744},"ffd602a7-ca89-4574-bcc5-3fc5f741d0ff",[87],[736],{"id":18,"sortIndex":19,"affiliation":737,"properties":18},{"id":738,"createTime":739,"updateTime":739,"relativeEntities":740,"slug":18,"properties":741,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"6f1609c9-b608-4a8b-b7b9-97a2413ea389","2023-12-23T10:08:52.630+00:00",[],{"title":742},{"VI":743},"Centro Médico de Especialistas Colsubsidio, Bogotá, Colombia",{"title":745},{"VI":746},"Richard Buendía",{"id":748,"sortIndex":183,"researcher":18,"roles":749,"affiliations":750,"properties":756},"4b6beacb-e261-4f97-a758-69dd56af825a",[87],[751],{"id":18,"sortIndex":19,"affiliation":752,"properties":18},{"id":706,"createTime":707,"updateTime":707,"relativeEntities":753,"slug":18,"properties":754,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":755},{"VI":711},{"title":757},{"VI":758},"Elsa Espinosa",{"id":760,"sortIndex":99,"researcher":18,"roles":761,"affiliations":762,"properties":773},"5d70fda1-6fec-43d7-96a7-93d2877a30cd",[87],[763],{"id":18,"sortIndex":19,"affiliation":764,"properties":18},{"id":765,"createTime":766,"updateTime":767,"relativeEntities":768,"slug":769,"properties":770,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a4a4b5e2-875c-4d52-8940-05a43bea034f","2024-02-10T01:23:10.744+00:00","2024-10-16T14:21:39.769+00:00",[],"Pontificia-Universidad-Javeriana-Bogot%C3%A1-Colombia",{"title":771},{"VI":772},"Pontificia Universidad Javeriana, Bogotá, Colombia",{"title":774},{"VI":775},"Mónica Zambrano",{"url":683,"publisher":777,"properties":792},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":778,"slug":10,"properties":779,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":782,"manageAffiliations":783,"indexDatabases":784,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":780,"title":781},{"VOID":13},{"EN":15},[],[],[785],{"id":44,"indexDatabase":786,"url":57,"indexYears":58,"academicFieldIds":791,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":787,"label":788,"description":789,"key":54,"publicationTags":790,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":793,"pages":794},{"VOID":377},{"VOID":795},"19-25","2016-01-01",{"id":798,"createTime":799,"updateTime":799,"relativeEntities":800,"slug":18,"properties":801,"entityType":79,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":808,"fullTextUrl":18,"authors":809,"publicationType":222,"publisherRelationship":871,"citationCount":18,"citationInfo":18,"publishDate":891,"publishYear":245,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"5b651900-ad5a-4520-bb4b-78aad5a626b5","2023-12-13T23:41:31.567+00:00",[],{"references":802,"title":804,"doi":806},{"VOID":803},"Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke., 22, 983, 10.1161\u002F01.STR.22.8.983\nKirchhof, 2016, ESC Guidelines for the management of atrial fibrillation developed in colla*boration with EACTS, Eur J Cardiothorac Surg. 2016, 10.1093\u002Fejcts\u002Fezw313\nRoselli, 2013, Prevalencia de fibrilación auricular en un hospital universitario colombiano, Rev Col Cardiol., 20, 383\nChugh, 2014, Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study, Circulation., 837, 10.1161\u002FCIRCULATIONAHA.113.005119\nBenjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation;, 98, 946, 10.1161\u002F01.CIR.98.10.946\nBjorck, 2013, Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study, Stroke, 44, 3103, 10.1161\u002FSTROKEAHA.113.002329\nHaim, 2015, Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation, J Am Heart Assoc, 4, e001486, 10.1161\u002FJAHA.114.001486\nWattigney, 2003, Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention, Circulation., 108, 711, 10.1161\u002F01.CIR.0000083722.42033.0A\nGladstone, 2009, Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated, Stroke., 40, 235, 10.1161\u002FSTROKEAHA.108.516344\nGattellari, 2011, Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management), Cerebrovasc Dis., 32, 370, 10.1159\u002F000330637\nGorin, 2011, Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.Chest., 140, 911\nPinto, 2016, Descripción de los pacientes con fibrilación auricular no valvular que ingresan al servicio de urgencias, Rev Colomb Cardiol., 23, 270\nSzymanski, 2015, Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of «High Stroke Risk» Patients With Atrial Fibrillation, Am J Cardiol, 10.1016\u002Fj.amjcard.2015.08.049\nKeogh, 2011, Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis, ThrombHaemost, 106, 528e538\nKarthikeyan, 2010, The CHADS2 score for stroke risk stratification in atrial fibrillation—friend or foe?, ThrombHaemost, 104, 45e48\nPisters, 2010, A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest., 138, 1093, 10.1378\u002Fchest.10-0134\nRaffaele De Caterinaand, 2014, What is ‘valvular’ atrial fibrillation?. A reappraisal, Eur Heart J., 35, 3328, 10.1093\u002Feurheartj\u002Fehu352\nOrtega, 2016, ¿Están correctamente anticoagulados nuestros pacientes con fibrilación auricular no valvular?, Rev Colomb Cardiol., 23, 361\nOldgren J, et al. RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014; 129(15):1568-76.\nJanuary CT, et al. ACC\u002FAHA Task Force Members. 2014 AHA\u002FACC\u002FHRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\u002FAmerican Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130(23):2071-104.\nQuinn RR, et al. Canadian Hypertension Education Program. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2010; 26(5):241-8.\nO’Reilly, 2013, The burden of atrial fibrillation on the hospital sector in Canada, Can J Cardiol., 29, 229, 10.1016\u002Fj.cjca.2012.03.023\nHan, 2018, Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK. BMJ Open., 8, e022558, 10.1136\u002Fbmjopen-2018-022558\nLamassa, 2001, Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project), Stroke., 32, 392, 10.1161\u002F01.STR.32.2.392\nBenjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation., 98, 946, 10.1161\u002F01.CIR.98.10.946\nHart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med., 146, 857, 10.7326\u002F0003-4819-146-12-200706190-00007\nConnolly SJ, et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139-51.\nFlaker, 2014, ARISTOTLE Committees and Investigators Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial, J Am Coll Cardiol., 64, 1541, 10.1016\u002Fj.jacc.2014.07.967\nKirchhof, 2009, Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference’research perspectives in AF’, Eur Heart J., 30, 2969, 10.1093\u002Feurheartj\u002Fehp235\nPenttilä, 2017, FinFib2 investigators Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort, Scand J Trauma Resusc Emerg Med., 25, 81, 10.1186\u002Fs13049-017-0424-7\nStiell, 2017, Outcomes for emergency department patients with recent-onset atrial fibrillation and flutter treated in canadian hospitals, Ann Emerg Med., 69, 562, 10.1016\u002Fj.annemergmed.2016.10.013\nBarbic, 2018, Implementation of an emergency department atrial fibrillation and flutter pathway improves rates of appropriate anticoagulation, reduces length of stay and thirty-day revisit rates for congestive heart failure, CJEM., 20, 392, 10.1017\u002Fcem.2017.418",{"ES":805},"Evaluación del tratamiento de la fibrilación auricular valvular y no valvular y su relación con eventos adversos en pacientes hospitalizados en el servicio de urgencias de un hospital de tercer nivel",{"VOID":807},"10.1016\u002Fj.rccar.2019.09.015","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563319301974",[810,825,837,849],{"id":811,"sortIndex":99,"researcher":18,"roles":812,"affiliations":813,"properties":822},"f212ce70-e0bb-425d-ba79-cb8af82135d9",[87],[814],{"id":18,"sortIndex":19,"affiliation":815,"properties":18},{"id":816,"createTime":817,"updateTime":817,"relativeEntities":818,"slug":18,"properties":819,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"541e687a-1c72-4582-8347-4871982c7fdb","2023-12-13T23:41:31.582+00:00",[],{"title":820},{"VI":821},"Hospital Santa Clara. Grupo Investigación Urgencias, Hospital Santa Clara, Bogotá, Colombia",{"title":823},{"VI":824},"Oscar Alberto Sáenz-Morales",{"id":826,"sortIndex":19,"researcher":18,"roles":827,"affiliations":828,"properties":834},"a15115a2-0fee-44ec-936c-e1cd6b3d5396",[87],[829],{"id":18,"sortIndex":19,"affiliation":830,"properties":18},{"id":816,"createTime":817,"updateTime":817,"relativeEntities":831,"slug":18,"properties":832,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":833},{"VI":821},{"title":835},{"VI":836},"Angélica María Rojas-Durán",{"id":838,"sortIndex":167,"researcher":18,"roles":839,"affiliations":840,"properties":846},"4d149e29-db80-409d-b95a-d980d7017660",[87],[841],{"id":18,"sortIndex":19,"affiliation":842,"properties":18},{"id":816,"createTime":817,"updateTime":817,"relativeEntities":843,"slug":18,"properties":844,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":845},{"VI":821},{"title":847},{"VI":848},"Erika Vergara-Vela",{"id":850,"sortIndex":196,"researcher":18,"roles":851,"affiliations":852,"properties":868},"35bd4a0b-daa9-40f3-9b7d-0caa4b6c5126",[87],[853,861],{"id":18,"sortIndex":19,"affiliation":854,"properties":18},{"id":855,"createTime":856,"updateTime":856,"relativeEntities":857,"slug":18,"properties":858,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"bcc22ea3-8fab-4205-a577-2a12bbbe7236","2024-01-11T11:25:27.457+00:00",[],{"title":859},{"VI":860},"Unidad de Cuidados Intensivos, Hospital Santa Clara, Bogotá, Colombia",{"id":862,"sortIndex":99,"affiliation":863,"properties":867},"d34f6750-4a7f-41ce-afef-4a28f4f6859f",{"id":706,"createTime":707,"updateTime":707,"relativeEntities":864,"slug":18,"properties":865,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":866},{"VI":711},{},{"title":869},{"VI":870},"Manuel Garay-Fernández",{"url":808,"publisher":872,"properties":887},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":873,"slug":10,"properties":874,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":877,"manageAffiliations":878,"indexDatabases":879,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":875,"title":876},{"VOID":13},{"EN":15},[],[],[880],{"id":44,"indexDatabase":881,"url":57,"indexYears":58,"academicFieldIds":886,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":882,"label":883,"description":884,"key":54,"publicationTags":885,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":888,"pages":889},{"VOID":241},{"VOID":890},"529-537","2020-11-01",{"id":893,"createTime":894,"updateTime":895,"relativeEntities":896,"slug":897,"properties":898,"entityType":79,"verifyStatus":80,"verifyTime":895,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":905,"fullTextUrl":18,"authors":906,"publicationType":222,"publisherRelationship":940,"citationCount":18,"citationInfo":18,"publishDate":960,"publishYear":245,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"6ab5234f-9232-46ec-8298-efbecb5017f7","2023-12-23T09:46:47.679+00:00","2024-10-17T23:34:20.665+00:00",[],"COVID-19-y-arritmias-relaci%C3%B3n-y-riesgo",{"references":899,"title":901,"doi":903},{"VOID":900},"Driggin, 2020, Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic, J Am Coll Cardiol., 75, 2352, 10.1016\u002Fj.jacc.2020.03.031\nEuropean Society of Cardiology. ESC Guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. 2020 https:\u002F\u002Fwww.escardio.org\u002Fstatic_file\u002FEscardio\u002FEducation-General\u002FTopic%20pages\u002FCovid-19\u002FESC%20Guidance%20Document\u002FESC-Guidance-COVID-19-Pandemic.pdf\nFigueroa F, Salas D, Cabrera J, Alvarado CC, Buitrago AF. COVID-19 y enfermedad cardiovascular. Rev Colom Cardiol. 2020, 10.1016.j.rccar.2020.04.004.\nGuo T, Fon Y, Chen M et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol Mar 27 doi: 10.1001\u002Fjama cardio. 2020.1017\nWang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan China. JAMA. 2020, https:\u002F\u002Fdoi.org\u002F10.1001\u002Fjama.2020.1585\nLazzerini, 2020, COVID-19, arrhythmic risk and inflammation: mind the gap, Circulation., 10.1161\u002FCIRCULATIONAHA.120.047293\nMehra M, Desai S, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020, https:\u002F\u002Fdoi.org\u002F10.1056\u002FNEJMoa2007621.\ndi Giacomo E, Bellelli G, Peschi G, Scarpetta S, Colmegna F1, de Girolamo G, et al. Management of older people during the COVID-19 outbreak: recommendations from a Italian experience. Int J Geriatr Psychiatry. 2020, https:\u002F\u002Fdoi.org\u002F10.1002\u002Fgps.5318.\nBaldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, et al. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med. 2020, https:\u002F\u002Fdoi.org\u002F10.1056\u002FNEJMc2010418.\nHe J, Wu B, Chen Y, Tang J, Liu Q, Zhou S et al. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol. 2020, https:\u002F\u002Fdoi.org\u002F10.1016\u002FJ.cjca.2020.03.028.\nSaavedra, 2020, Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-Co-2\u002FCOVID-19 en establecimientos de atención de la salud, Infectio., 3, 1, 10.22354\u002Fin.v24i3.851\nYao X, Ye F, Zhang, Cheng Cui, Baoying Huang, Peihua Niu, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Clin Infect Dis. 2020, https:\u002F\u002Fdoi.org\u002F10.1093\u002Fcid\u002Fciaa237.\nSapp JL, Alqarawi W, MacIntyre CJ, Tadros R, Steinberg C, Roberts JD, et al. Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society. Can J Cardiol. 2020, https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.cjca.2020.04.003\nSarayani, 2020, Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without choloroquine or hydroxichloroquine, Res Social Adm Pharm., 10.1016\u002Fj.sapharm.2020.04.016\nGuzik T, Mohiddin S, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020, https:\u002F\u002Fdoi.org\u002F10.1093\u002Fcvr\u002Fcvaa106\nvan de Brock MPH, Mölmann JE, Abel BGS, Liebregts M, van Dijk VF, van de Garde EMWl. Chloroquine-induced QTc prolongation in COVID-19 patients. Neth Heart J. 2020, 10.1007s12471-020-01429-7.\nSilva, 2020, Effect of high vs low doses of chloroquine diphosphate as adjuntive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A randomized clinical trial, JAMA Netw open\nSaleh M, Gabriels J, Chany D, Soo Kim B, Mansoor A, Mahmood E, et al. The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARSCoV-2 Infection. Cir Arhythm Electrophysiol. 2020, https:\u002F\u002Fdoi.org\u002F10.1161\u002FCIRCEP.120.008662\nMercuro, 2020, Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19), JAMA Cardiology, 10.1001\u002Fjamacardio.2020.1834\nBessiere, 2020, Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxichloroquine alone or in combination with azithromycin in an intensive care unit, JAMA Cardiol., 10.1001\u002Fjamacardio.2020.1787\nMehra, 2020, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry análisis, Lancet.\nGautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial. Int J Antimicrob Agents. 2020;20:105949, https:\u002F\u002Fdoi.org\u002F10.1016\u002Fjantimicag.2020.105949\nRay WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Eng J Med. 2012:3661881-90, https:\u002F\u002Fdoi.org\u002F10.1056\u002FNEJMoa1003833\nCao B, Wang D, Wen W, Liu W, Wang J, Fan G, et al. A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Eng J Med. 2020, https:\u002F\u002Fdoi.org\u002F10.1056\u002FN EJMoa2001282.\nGrein J, Ohmagari D, Shing G, Diaz G, Asperges E, Castagna A, et al. Compassionate use of remdesivir for patients with severe COVID-19. N. Eng J Med. 2020, https:\u002F\u002Fdoi.org\u002F10.1056\u002FNEJMoa2007016\nWang Y, Zhang D, Du G Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomized double-blind, placebo-controlled, multicenter trial. Lancet. 2020, https:\u002F\u002Fdoi.org\u002F10.1016\u002FS0140-6736(20)31022-9\nWo Ch, Postema P, Arbelo E, Behr ER, Bezzina CR, Napolitano C, et al. SARS-COV-2, COVID-19 and inherited arrythmia syndromes. Heart Rhythm. 2020 Mar 31, https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.hrthm.2020.03.024\nChang D, Saleh M, Garcia-Bengo Y, Choi E, Epstein L, Willner J. COVID-19 infection unmasking Brugada Syndrome. Heart Rhythm Case Rep. 2020, https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.hrcr.2020.023.012\nAsencio E, Acunzo R, Uribe W, Saad E, Saenz L. Recomendaciones para la medición del intervalo QT durante el uso de medicamentos para el tratamiento de infección por COVID-19. https:\u002F\u002Fwww.sociedadsadec.org.ar\u002Fwp-content\u002Fuploads\u002F2020\u002F04\u002FRECOMENDACIONES-PARA-LA-MEDICION-DEL-INTERVALO-QT-DURANTE-EL-USO-DE-MEDICAMENTOS-PARA-EL-TRATAMIENTO-DE-INFECCION-POR-COVID.pdf.pdf.\nCheung C, Davier B, Gibbs K, et al. MultiLead QT screening is necessary for QT measurement: Implications for management of patients in the Covid-19 Era. JACC Clin Electrophys doi:10.1016\u002Fj.jacep.2020.04.001\nZareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of genotype on the clinical course of the long-QT syndrome International long-QT syndrome registry research group. N Eng J Med. 1998;339:960-5.\nTisdale J, Jaynes H, Kingery J, Mourad NA, Trujillo TN, Overholser BR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Cir Cardiovascular Qual Outcomes. 2013;6:479-87, https:\u002F\u002Fdoi.org\u002F10.1161\u002FCIRCOUTCOMES.113.000152\nGiudecessi, 2020, Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potencial of possible pharmacotherapies for COVID-19, Mayo Clinic Proc., 10.1016\u002Fj.mayocp.2020.03.024\nRoden, 2020, Considerations for drug Interactions on QTc in exploratory COVID-19 (coronavirus disease 2019) treatment, Circulation., 10.1161\u002FCIRCULATIONAHA.120.047521\nKaye, 2002, Role of magnesium in the emergency department, Emerg Med J., 19, 288, 10.1136\u002Femj.19.4.288\nDiness T, Yeh Q, Qi XY, Chartier D, Tsuji Y, Hansen RS, et al. Antiarrhythmic properties of rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. Cardiovasc Res. 2008;79:61-9, https:\u002F\u002Fdoi.org\u002F10.1093\u002Fcvr\u002Fcvn075\nEl-Sheif, 2019, Acquired long QT syndrome and electrophysiology of torsade de pointes, Arrhythm Electrophysiol Rev., 2, 122, 10.15420\u002Faer.2019.8.3",{"ES":902},"COVID-19 y arritmias: relación y riesgo",{"VOID":904},"10.1016\u002Fj.rccar.2020.05.004","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563320300930",[907],{"id":908,"sortIndex":19,"researcher":18,"roles":909,"affiliations":910,"properties":937},"d0c0c1b0-507b-4344-8943-c5a738b4d4e2",[87],[911,921,932],{"id":912,"sortIndex":99,"affiliation":913,"properties":920},"959bb755-6ddb-4dfa-8d9a-2d36b14b4859",{"id":914,"createTime":915,"updateTime":915,"relativeEntities":916,"slug":18,"properties":917,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"bc05d207-b705-47d9-80f2-fd88e17b403b","2024-01-22T10:33:41.705+00:00",[],{"title":918},{"VI":919},"Fundación Santafé de Bogotá, Bogotá, Colombia",{},{"id":922,"sortIndex":196,"affiliation":923,"properties":931},"c30ba48d-16f8-49bc-a9f2-f6be04b55b28",{"id":924,"createTime":925,"updateTime":925,"relativeEntities":926,"slug":927,"properties":928,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"aab19386-a2ec-49ea-b023-e4b5eb5222a6","2023-11-28T03:03:54.161+00:00",[],"Los-Cobos-Medical-Center-Bogot%C3%A1-Colombia",{"title":929},{"VI":930},"Los Cobos Medical Center, Bogotá, Colombia",{},{"id":18,"sortIndex":19,"affiliation":933,"properties":18},{"id":721,"createTime":722,"updateTime":723,"relativeEntities":934,"slug":725,"properties":935,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":936},{"VI":728},{"title":938},{"VI":939},"Guillermo Mora",{"url":905,"publisher":941,"properties":956},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":942,"slug":10,"properties":943,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":946,"manageAffiliations":947,"indexDatabases":948,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":944,"title":945},{"VOID":13},{"EN":15},[],[],[949],{"id":44,"indexDatabase":950,"url":57,"indexYears":58,"academicFieldIds":955,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":951,"label":952,"description":953,"key":54,"publicationTags":954,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],{"volume":957,"pages":958},{"VOID":241},{"VOID":959},"153-159","2020-05-01",{"id":962,"createTime":963,"updateTime":964,"relativeEntities":965,"slug":966,"properties":967,"entityType":79,"verifyStatus":80,"verifyTime":964,"verifyNote":81,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":974,"fullTextUrl":18,"authors":975,"publicationType":222,"publisherRelationship":1031,"citationCount":18,"citationInfo":18,"publishDate":1047,"publishYear":1048,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":246},"a7a54185-c65a-4af5-8710-f7ef0d1a3143","2023-12-27T02:32:37.674+00:00","2024-12-11T23:31:40.927+00:00",[],"WITHDRAWN-Otra-faceta-de-la-evaluaci%C3%B3n-del-riesgo-la-importancia-de-conocer-el-nuestro",{"references":968,"title":970,"doi":972},{"VOID":969},"Hirshfeld, 2018, J Am Coll Cardiol., 71, 2811, 10.1016\u002Fj.jacc.2018.02.017\nBadel, 2018, Radiación ionizante: revisión de tema y recomendaciones para la práctica, Rev Col Cardiol.\nDurán, 2013, Recommendations for occupational radiation protection in interventional cardiology, Cathet Cardiovasc Intervent., 82, 29, 10.1002\u002Fccd.24694\nFaroux, 2017, Trends in patient exposure to radiation in percutaneous coronary interventions over a 10-year period, Am J Cardiol., 120, 927, 10.1016\u002Fj.amjcard.2017.06.021\nRoguin, 2013, Cardiol, 111, 1368, 10.1016\u002Fj.amjcard.2012.12.060\nHonorio da Silva, 2018, Effect of protective devices on the radiation dose received by the brains of interventional cardiologists, EuroIntervention., 13, e1778, 10.4244\u002FEIJ-D-17-00759",{"EN":971},"WITHDRAWN: Otra faceta de la evaluación del riesgo: la importancia de conocer el nuestro",{"VOID":973},"10.1016\u002Fj.rccar.2018.08.011","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0120563319301779",[976],{"id":977,"sortIndex":19,"researcher":18,"roles":978,"affiliations":979,"properties":1028},"0dc3e8bc-7fc3-4ff5-a6a6-71091ddc23d7",[87],[980,988,998,1008,1018],{"id":18,"sortIndex":19,"affiliation":981,"properties":18},{"id":982,"createTime":983,"updateTime":983,"relativeEntities":984,"slug":18,"properties":985,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"d7a54fb5-83ff-41c0-91a5-83d0bde48ca1","2023-12-07T12:15:00.623+00:00",[],{"title":986},{"VI":987},"CES Cardiología, Universidad CES, Medellín, Colombia",{"id":989,"sortIndex":196,"affiliation":990,"properties":997},"a53d992c-17ba-4ddc-9588-f70682acf31f",{"id":991,"createTime":992,"updateTime":992,"relativeEntities":993,"slug":18,"properties":994,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"fbaa7d8a-d2cd-43d4-9de4-47d9e27163f3","2023-12-22T23:24:00.443+00:00",[],{"title":995},{"VI":996},"Clínica El Rosario, Medellín, Colombia",{},{"id":999,"sortIndex":99,"affiliation":1000,"properties":1007},"ada0d272-a502-4878-9961-122223b548af",{"id":1001,"createTime":1002,"updateTime":1002,"relativeEntities":1003,"slug":18,"properties":1004,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"4c4b9e7a-9bae-44ce-851b-1a2a68e3cf5a","2023-12-07T12:15:00.575+00:00",[],{"title":1005},{"VI":1006},"Clínica Las Américas, Medellín, Colombia",{},{"id":1009,"sortIndex":40,"affiliation":1010,"properties":1017},"1e0d103c-079d-4008-8844-8a2a360511da",{"id":1011,"createTime":1012,"updateTime":1012,"relativeEntities":1013,"slug":18,"properties":1014,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"7c9e9e45-3370-4069-8b9c-1783b824292c","2023-12-27T02:32:37.725+00:00",[],{"title":1015},{"VI":1016},"Clínica CES, Medellín, Colombia",{},{"id":1019,"sortIndex":167,"affiliation":1020,"properties":1027},"eb59ea64-619d-4afc-abd3-548f468834b5",{"id":1021,"createTime":1022,"updateTime":1022,"relativeEntities":1023,"slug":18,"properties":1024,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"e70854b3-56e0-48bd-92bb-d4882fda9250","2023-12-27T02:32:37.720+00:00",[],{"title":1025},{"VI":1026},"Clínica Las Vegas, Medellín, Colombia",{},{"title":1029},{"VI":1030},"Julián Aristizábal",{"url":974,"publisher":1032,"properties":18},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1033,"slug":10,"properties":1034,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1037,"manageAffiliations":1038,"indexDatabases":1039,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1035,"title":1036},{"VOID":13},{"EN":15},[],[],[1040],{"id":44,"indexDatabase":1041,"url":57,"indexYears":58,"academicFieldIds":1046,"indexDatabaseRanking":61},{"id":46,"createTime":47,"updateTime":48,"relativeEntities":1042,"label":1043,"description":1044,"key":54,"publicationTags":1045,"standard":18},[],{"EN":51,"VI":51},{"EN":51,"VI":53},[56],[60],"2019-11-01",2019]